Markets
BSE See NSE See 29,409.52
176.08 (0.6%)
collapse Related Readings collapse

Aurobindo Pharma Gets USFDA Approval For Generic Diovan HCT

By Shrikant Akolkar | 3/22/2013 3:42 PM Friday

Aurobindo Pharma has reported receiving final approval for the Valsartan and Hydrochlorothiazide tablets (brand name Diovan HCT held by Novartis). The drug is indicated in the treatment of hypertension to lower blood pressure. The market size of this drug is USD 1.7 billion (Rs 9350 crore) as per the company’s BSE filings. Aurobindo has said that the product is ready for launch and that this will happen soon.

Drug major Mylan has already launched an authorised generic version of this drug in USA. We believe that Aurobindo is the first to launch the generic of this drug considering that Mylan’s was an authorised generic.

We spoke to the company spokesperson, who declined to comment on the pricing and market share of the drug. However, he did say that the company expects to see about 3-4 generic players in the market. Considering this, about 20% market share looks achievable for Aurobindo. Since it is the first to launch, there would not be a massive erosion of price initially. However, as the drug has already fallen out of patent cover, new players would try to enter the market as faster as possible. Once other companies start launching their versions of the drug, the price will go down.

Considering 80% price erosion and 10% market share for Aurobindo, it can be estimated that the company may achieve revenues of about Rs 700 crore from the drug. Of course, these numbers are based on the assumption that the company makes the best of this opportunity.

With this approval, Aurobindo Pharma has a total of 181 ANDA approvals from USFDA, of which 156 are final and 25 are tentative approvals.

Find More Articles on: Markets, DSIJ Mindshare, Product, Large Cap

news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »

DSIJ
Mindshare

BSE to suspend 7 company’s trading for non-compliance of Regulation 55A

BSE to suspend 7 company’s trading for non-compliance of Regulation 55A

BSE will suspend seven companies from trading their securities on the stock exchange from April 18 for failing to comply with certain rules for two consecutive quarters.

43 CPSEs in the red since last 3 years, informs MoS

43 CPSEs in the red since last 3 years, informs MoS

Babul Surpiyo, Minister of State for Heavy Industries and Public Entreprises, informed the parliament today that there are as many as 43 central public sector enterprises (CPSEs) which includes Air India and BSNL that are making losses over the last three consecutive years.

Skymet Weather forecasts 95% monsoon in 2017

Skymet Weather forecasts 95% monsoon in 2017

According to Skymet Weather forecast, monsoon in India this year is likely to remain below normal at 95 per cent (with an error margin of +/-5 per cent).

Overnight Digest- Stocks to look out for on March 29

Overnight Digest- Stocks to look out for on March 29

The stocks which are expected to witness significant movement on March 29 are Karnataka Bank, Britannia, V-Guard Industries, ICICI Bank, Nestle India.

SBI spends Rs 775 crore to maintain Jan Dhan accounts!

SBI spends Rs 775 crore to maintain Jan Dhan accounts!

The total balance in PMJDY stood at Rs 71,036 crore as on December 28, 2016. Divulging further details, the MoS informed that public sector banks, regional banks and 13 private banks have reported that nearly 95,52,609 accounts were frozen under the PMJDY.

Market
CHIT CHAT

What is your view on markets today?

200  Characters Remaining.
Please LOGIN  to post your comments or Click here to go back.
punkesh kumar Mar 29 01:28AM
How do i buy a stock
amarjeet jaiswal Mar 29 12:08AM
Network 985725 cash balance 1000737.74 my actual balance is what please tell me
shiv kumar Mar 28 08:39PM
What happened to iol chemical??
karthick ponraj Mar 28 04:06PM
Cannot cover short stocks within 4 clock on next day cannot order for short
The King Mar 28 03:24PM
not sure @senthil, each day in mkt is diff.